GSK-Vir COVID-19 Antibody Works as Shot in the Arm
(Reuters) – Britain’s GSK and partner Vir said on Friday their antibody-based COVID-19 drug was shown in a trial to
Read more
(Reuters) – Britain’s GSK and partner Vir said on Friday their antibody-based COVID-19 drug was shown in a trial to
Read more